Platelet protein kinase C and brain-derived neurotrophic factor levels in borderline personality disorder patients

Psychiatry Research

Volumn 199, Issue 2, 2012, Pages 92-97

  Koenigsberg, Harold W ^a,b   Yuan, Peixiong ^c   Diaz, George A ^a   Guerreri, Stephanie ^a   Dorantes, Christine ^a   Mayson, SarahJo ^a   Zamfirescu, Constantin ^a   New, Antonia S ^a,b   Goodman, Marianne ^a,b   Manji, Husseini K ^d   Siever, Larry J ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^d JOHNSON AND JOHNSON   (United States)

Author keywords

BDNF; Borderline personality disorder; Neurotrophic factors; Personality disorders; PKC; Second messengers

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; PROTEIN KINASE C; PROTEIN KINASE C ALPHA; PROTEIN KINASE C BETA; PROTEIN KINASE C BETA III; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BORDERLINE STATE; CELL FREE SYSTEM; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; ENZYME ACTIVITY; FEMALE; HUMAN; IMMUNOBLOTTING; MALE; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; THROMBOCYTE;

ADULT; BLOOD PLATELETS; BLOTTING, WESTERN; BORDERLINE PERSONALITY DISORDER; BRAIN-DERIVED NEUROTROPHIC FACTOR; CASE-CONTROL STUDIES; FEMALE; HUMANS; ISOENZYMES; MALE; PROTEIN KINASE C;

EID: 84869198825     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2012.04.026     Document Type: Article

References (42)

1. Akin D., Manier D.H., Sanders-Bush E., Shelton R.C. Signal transduction abnormalities in melancholic depression. International Journal of Neuropsychopharmacology 2005, 8:5-16.
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994, APA, Washington DC. 4th ed.
3. Coull M.A., Lowther S., Katona C.L., Horton R.W. Altered brain protein kinase C in depression: a post-mortem study. European Neuropsychopharmacology 2000, 10:283-288.
4. DiazGranados N., Zarate C.A. A review of the preclinical and clinical evidence for protein kinase C as a target for drug development for bipolar disorder. Current Psychiatry Reports 2008, 10:510-519.
5. Dwivedi Y., Rizavi H.S., Conley R.R., Roberts R.C., Tamminga C.A., Pandey G.N. Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Archives of General Psychiatry 2003, 60:804-815.
6. Fernandes B.S., Gama C.S., Maria Cereser K., Yatham L.N., Fries G.R., Colpo G., de Lucena D., Kunz M., Gomes F.A., Kapczinski F. Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and meta-regression analysis. Journal of Psychiatric Research 2011.
7. Friedman E., Hoau Yan W., Levinson D., Connell T.A., Singh H. Altered platelet protein kinase C activity in bipolar affective disorder, manic episode. Biological Psychiatry 1993, 33:520-525.
8. Gould T.D., Manji H.K. Signaling networks in the pathophysiology and treatment of mood disorders. Journal of Psychosomatic Research 2002, 53:687-697.
9. Grant B.F., Chou S.P., Goldstein R.B., Huang B., Stinson F.S., Saha T.D., Smith S.M., Dawson D.A., Pulay A.J., Pickering R.P., Ruan W.J. Prevalence, correlates, disability, and comorbidity of DSM-IV borderline personality disorder: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Clinical Psychiatry 2008, 69:533-545.
10. Harvey P.D., Greenberg B.R., Serper M.R. The affective lability scales: development, reliability, and validity. Journal of Clinical Psychology 1989, 45:786-793.
11. Hashimoto K. Brain-derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directions. Psychiatry and Clinical Neurosciences 2010, 64:341-357.
12. Hrdina P., Faludi G., Li Q., Bendotti C., Tekes K., Sotonyi P., Palkovits M. Growth-associated protein (GAP-43), its mRNA, and protein kinase C (PKC) isoenzymes in brain regions of depressed suicides. Molecular Psychiatry 1998, 3:411-418.
13. Karege F., Bondolfi G., Gervasoni N., Schwald M., Aubry J.M., Bertschy G. Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity. Biological Psychiatry 2005, 57:1068-1072.
14. Karege F., Vaudan G., Schwald M., Perroud N., La Harpe R. Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs. Brain Research Molecular Brain Research 2005, 136:29-37.
15. Koenigsberg H.W., Anwunah I., New A.S., Mitropoulou V., Schopick F., Siever L.J. Relationship between depression and borderline personality disorder. Depression and Anxiety 1999, 10:158-167.
16. Koenigsberg, H.W., Harvey, P.D., Mitropoulou, V.J.2002. Characterizing affective instability in borderline personality disorderAmerican Journal of Psychiatry.
17. Koenigsberg H.W., Harvey P.D., Mitropoulou V., New A.S. Are the interpersonal and identity disturbances in the borderline personality disorder criteria. Journal of Personality Disorders 2001.
18. Koenigsberg H.W., Woo-Ming A.M., Siever L.J. Psychopharmacological treatment of personality disorders. A Guide to Treatments that Work 2007, Oxford University Press, New York. third ed. P.E. Nathan, J.M. Gorman (Eds.).
19. Lee B.H., Kim Y.K. Reduced platelet BDNF level in patients with major depression. Progress in Neuro-Psychopharmacol & Biological Psychiatry 2009, 33:849-853.
20. Manji H.K., Lenox R.H. Ziskind-Somerfeld Research Award. Protein kinase C signaling in the brain: molecular transduction of mood stabilization in the treatment of manic-depressive illness. Biological Psychiatry 1999, 46:1328-1351.
21. Mann C.D., Vu T.B., Hrdina P.D. Protein kinase C in rat brain cortex and hippocampus: effect of repeated administration of fluoxetine and desipramine. British Journal of Pharmacology 1995, 115:595-600.
22. Numakawa T., Suzuki S., Kumamaru E., Adachi N., Richards M., Kunugi H. BDNF function and intracellular signaling in neurons. Histology and Histopathology 2010, 25:237-258.
23. Pan W., Banks W.A., Fasold M.B., Bluth J., Kastin A.J. Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology 1998, 37:1553-1561.
24. Pandey G.N., Dwivedi Y., Kumari R., Janicak P.G. Protein kinase C in platelets of depressed patients. Biological Psychiatry 1998, 44:909-911.
25. Pandey G.N., Dwivedi Y., Pandey S.C., Conley R.R., Roberts R.C., Tamminga C.A. Protein kinase C in the postmortem brain of teenage suicide victims. Neuroscience Letters 1997, 228:111-114.
26. Pandey G.N., Dwivedi Y., Rizavi H.S., Ren X., Conley R.R. Decreased catalytic activity and expression of protein kinase C isozymes in teenage suicide victims: a postmortem brain study. Archives of General Psychiatry 2004, 61:685-693.
27. Pandey G.N., Dwivedi Y., Rizavi H.S., Ren X., Zhang H., Pavuluri M.N. Brain-derived neurotrophic factor gene and protein expression in pediatric and adult depressed subjects. Progress in Neuropsychopharmacology and Biological Psychiatry 2010, 34:645-651.
28. Pandey G.N., Dwivedi Y., SridharaRao J., Ren X., Janicak P.G., Sharma R. Protein kinase C and phospholipase C activity and expression of their specific isozymes is decreased and expression of MARCKS is increased in platelets of bipolar but not in unipolar patients. Neuropsychopharmacology 2002, 26:216-228.
29. Perugi G., Toni C., Travierso M.C., Akiskal H.S. The role of cyclothymia in atypical depression: toward a data-based reconceptualization of the borderline-bipolar II connection. Journal of Affective Disorders 2003, 73:87-98.
30. Post R.M. Role of BDNF in bipolar and unipolar disorder: clinical and theoretical implications. Journal of Psychiatric Research 2007, 41:979-990.
31. Rosse C., Linch M., Kermorgant S., Cameron A.J., Boeckeler K., Parker P.J. PKC and the control of localized signal dynamics. Nature Reviews Molecular Cell Biology 2010, 11:103-112.
32. Sen S., Duman R., Sanacora G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biological Psychiatry 2008, 64:527-532.
33. Serra-Millas M., Lopez-Vilchez I., Navarro V., Galan A.M., Escolar G., Penades R., Catalan R., Fananas L., Arias B., Gasto C. Changes in plasma and platelet BDNF levels induced by S-citalopram in major depression. Psychopharmacology (Berlin) 2011, 216:1-8.
34. Shelton R.C., Hal Manier D., Lewis D.A. Protein kinases A and C in post-mortem prefrontal cortex from persons with major depression and normal controls. International Journal of Neuropsychopharmacology 2009, 12:1223-1232.
35. Skodol A.E., Gunderson J.G., Pfohl B., Widiger T.A., Livesley W.J., Siever L.J. The borderline diagnosis I: psychopathology, comorbidity, and personality structure. Biological Psychiatry 2002, 51:936-950.
36. Smith D.J., Muir W.J., Blackwood D.H. Is borderline personality disorder part of the bipolar spectrum?. Harvard Review of Psychiatry 2004, 12:133-139.
37. Steinberg B.J., Trestman R., Mitropoulou V., Serby M., Silverman J., Coccaro E., Weston S., de Vegvar M., Siever L.J. Depressive response to physostigmine challenge in borderline personality disorder patients. Neuropsychopharmacology 1997, 17:264-273.
38. Wang H.Y., Friedman E. Enhanced protein kinase C activity and translocation in bipolar affective disorder brains. Biological Psychiatry 1996, 40:568-575.
39. Wang H.Y., Markowitz P., Levinson D., Undie A.S., Friedman E. Increased membrane-associated protein kinase C activity and translocation in blood platelets from bipolar affective disorder patients. Journal of Psychiatric Research 1999, 33:171-179.
40. Yang J., Siao C.J., Nagappan G., Marinic T., Jing D., McGrath K., Chen Z.Y., Mark W., Tessarollo L., Lee F.S., Lu B., Hempstead B.L. Neuronal release of proBDNF. Nature Neuroscience 2009, 12:113-115.
41. Yuan P.X., Huang L.D., Jiang Y.M., Gutkind J.S., Manji H.K., Chen G. The mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth. Journal of Biological Chemistry 2001, 276:31674-31683.
42. Zarate C.A., Manji H.K. Protein kinase C inhibitors: rationale for use and potential in the treatment of bipolar disorder. CNS Drugs 2009, 23:569-582.